Clinical trial
Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)
NCT00446056 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00446056 |
|---|---|
| Title | Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379) |
| Official title | Montelukast, on Pediatric Bronchial Asthma in Multicenter Comparative Double-Blind Clinical Study (Phase IV) With Ketotifen Fumarate |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | MK0476, montelukast sodium / Duration of Treatment: 4 Weeks, Comparator: ketotifen / Duration of Treatment: 4 Weeks |
| Enrollment | 188 |
| Start date | Sep 25, 2003 |
| Primary completion | Jun 16, 2004 |
| Completion | Jun 16, 2004 |
| First posted | Mar 12, 2007 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: